MuST: Must Cannulation Technique of Vascular Access in Patients Undergoing Haemodialysis: Contributions for a Safe Nursing Intervention

Sponsor
Fresenius Medical Care Deutschland GmbH (Industry)
Overall Status
Recruiting
CT.gov ID
NCT05081648
Collaborator
University of Lisbon (Other), Lisbon Nursing School (Other)
200
3
2
20.9
66.7
3.2

Study Details

Study Description

Brief Summary

The aims of this study are to:
  • Determine the AVF (arteriovenous fistula) survival of patients submitted to MuST compared to those submitted to RL (rope-ladder).

  • Determine the AVF (arteriovenous fistula) complication rate of patients submitted to MuST compared to those submitted to RL (rope-ladder).

  • Analyze the intensity of pain perceived by the patient with each cannulation technique under study.

Condition or Disease Intervention/Treatment Phase
  • Procedure: CT MuST
  • Procedure: Rope-ladder cannulation technique
N/A

Detailed Description

The MuST is based on the association between the RL technique in that it uses the entire length of the available vessel through progressive rotation, and the buttonhole (BH) cannulation technique since there are three specific cannulation sites for each cannulation day during the week, meaning that each site is only cannulated once a week (allowing the puncture site to heal in between cannulations).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
multiple-center, prospective, non-blind, parallel-group, randomized controlledmultiple-center, prospective, non-blind, parallel-group, randomized controlled
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Randomised Control Trial of MuST Technique for Vascular Access Cannulation in Hemodialysis Patients: Contributions for a Safe Nursing Intervention
Actual Study Start Date :
Jan 3, 2022
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Sep 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention group: Multiple Single Cannulation Technique (MuST)

Procedure: CT MuST
Multiple Single Cannulation Technique (MuST): Experimental technique

Other: Control group: Rope-ladder cannulation technique (RL)

Procedure: Rope-ladder cannulation technique
Standard cannulation technique( Rope-ladder)

Outcome Measures

Primary Outcome Measures

  1. Vascular access survival rate [12 months after start of study]

    Vascular access (VA) survival rate at 12 months and determined by the percentage of fistulas in use from the beginning of the study to the date of the first clinical intervention by angioplasty or vascular surgery, to maintain or restore patency - "unassisted patency".

Secondary Outcome Measures

  1. Arteriovenous fistula survival rate [12 months after start of study]

    Arteriovenous fistula (AVF) survival rate at 12-month and determined by the percentage of fistulas in use from the study start to the date of access abandonment due to dysfunction, patient abandonment, or death, treatment change modality or study end.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Voluntarily agree to participate in the study and sign an informed consent;

  • Are on a regular haemodialysis (HD) program with three weekly sessions;

  • AVF has been in use for at least 4 weeks without incident;

  • AVF with blood flow (Qa) ≥500 mL/min evaluated by thermodilution;

  • AVF paths allow cannulations along the entire length of the vein with at least 6 cm of distance between bevels, or two distinct areas of 3 cm in length;

  • Adult patients

Exclusion Criteria:
  • Those who decline to take part;

  • Those who have undergone angiography or surgical intervention in the last 4 months in the AVF in use;

  • Those who have undergone three or more interventions in the AVF in use;

  • Those with use of anesthetic creams at cannulation sites.

Contacts and Locations

Locations

Site City State Country Postal Code
1 NephroCare Coimbra Coimbra Portugal 3025-04
2 Nephrocare Montijo Montijo Portugal 2870-281
3 NephroCare Vila Nova de Gaia Vila Nova De Gaia Portugal 4430-703

Sponsors and Collaborators

  • Fresenius Medical Care Deutschland GmbH
  • University of Lisbon
  • Lisbon Nursing School

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fresenius Medical Care Deutschland GmbH
ClinicalTrials.gov Identifier:
NCT05081648
Other Study ID Numbers:
  • HD-MuST-01-PT
First Posted:
Oct 18, 2021
Last Update Posted:
Feb 7, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Fresenius Medical Care Deutschland GmbH
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 7, 2022